ArticleFrontiers in pharmacology2026

Dual MAO A and HSP90 inhibitors enhance anti-PD-1 therapy and suppress colorectal cancer.

Hui-Ju Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.